Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
| 説明 | Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways. |
| 植物由来 |
| 別名 | Astrasieversianin VIII |
| 分子量 | 798.95 |
| 分子式 | C41H66O15 |
| CAS No. | 84676-89-1 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
H2O: < 0.1 mg/mL (insoluble)
DMSO: 100 mg/mL (120.92 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
参考文献
投与量変換You can also refer to dose conversion for different animals. 詳細
In vivo投与量計算 (透明溶液)計算器bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Astragaloside II 84676-89-1 Stem Cells TGF-beta/Smad Inhibitor inhibit Astrasieversianin VIII inhibitor
